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access article under the CC BY-NC-NDSummary In vitro and in vivo studies evidenced that mesenchymal stem cells (MSCs)
contribute to intervertebral disc (IVD) regeneration by differentiation towards the disc pheno-
type and matrix synthesis and/or by paracrine signalling to endogenous cells, thereby promot-
ing a healthier disc phenotype in degenerative discs. The aim of this study was to investigate
IVD response to human MSC (hMSC) treatment based on the disc degenerative state and hMSC
carrier. Bovine caudal IVDs with endplates were cultured in a bioreactor under simulated phys-
iological (0.1 Hz load and sufficient glucose) or degenerative (10 Hz load and limited glucose)
conditions for 7 days. Discs were partially nucleotomised, restored with hMSCs in either fibrin
gel or saline solution and cultured under physiological conditions for 7 days. Controls included
fibrin and saline without hMSCs. Cell viability, histology, disc height, and gene expression an-
alyses were performed to evaluate regeneration. hMSCs in fibrin were viable and homoge-
nously distributed following 7 days of culture under dynamic loading in partially
nucleotomised discs. IVD response to hMSCs was conditioned by both disc degenerative state
and hMSC carrier. The effect of the regenerative treatment was stronger on simulated-
degenerative discs than on simulated-physiological discs. hMSCs in fibrin induced a superior
anabolic response in degenerative IVDs compared with fibrin alone, thus suggesting an added
value of the cellular therapy compared with an acellular solution. When comparing fibrin and
saline as a hMSC carrier, a significantly higher anabolic response was observed in IVDs treated
with hMSCs in fibrin. Moreover, it was found that the degenerative state of the disc influenced
hMSC differentiation. Indeed, a significantly higher expression of specific discogenic markers
(ACAN and CA12) was observed in hMSCs implanted into physiological discs than in those im-
planted into degenerative discs. In conclusion, host disc cells and donor hMSC response depend
on the degenerative state of the host disc and carrier used for hMSC delivery, and these twoInstitute Davos, Clavadelerstrasse 8, 7270 Davos, Switzerland.
@aofoundation.org (M. Peroglio).
03.003
hed by Elsevier (Singapore) Pte Ltd on behalf of Chinese Speaking Orthopaedic Society. This is an open
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
44 M. Peroglio et al.aspects need to be considered for a successful translation of hMSC therapies for the treatment
of IVD degeneration.
ª 2017 The Authors. Published by Elsevier (Singapore) Pte Ltd on behalf of Chinese Speaking
Orthopaedic Society. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
An important hallmark of intervertebral disc (IVD) degen-
eration is the marked decrease in the number of viable and
functionally active endogenous cell populations [1].
Therefore, cell transplantation therapies have widely been
investigated for IVD regeneration. In particular, regenera-
tive effects of bone marrow-derived mesenchymal stem
cells (MSCs) have been reported in vitro in preclinical
studies and in some clinical trials [2,3]. Compared with
differentiated IVD cells, the main advantages of MSCs
include their almost unlimited availability, the one-step
isolation procedure, and their high proliferation and mul-
tilineage differentiation capability [4].
While promising results were reported from preclinical
and clinical studies, recent work has focused on the
mechanisms underlying MSCs effects on IVD cells and tis-
sues. Thus, two complementary roles have been attributed
to the MSCs that may contribute to tissue regeneration [5].
First, MSCs can acquire an IVD-like phenotype under
appropriate culture conditions or in co-culture with IVD
cells, thereby directly contributing to new matrix synthesis.
Factors that may promote a chondrocytic or IVD-like
phenotype include low oxygen conditions, hydrostatic
pressure or mechanical compressive loading, growth factor
supplementation, and co-culture with native IVD cells
[6e9]. Moreover, in vitro and in vivo studies demonstrated
an increased expression of chondrocytic/IVD markers in
MSCs injected into the IVD in rat tail and rabbit disc
degeneration models [10e12]. Second, anabolic, anti-
inflammatory, and anti-apoptotic properties have been
attributed to the implanted MSCs [13]. In vitro coculture
experiments demonstrated stimulatory effects of MSCs on
the proliferation and extracellular matrix synthesis of nu-
cleus pulposus (NP) and annulus fibrous (AF) cells [14,15].
Furthermore, MSCs supplementation was effective in sup-
pressing pro-inflammatory markers in degenerative and
inflammatory cell and tissue culture models [16,17]. These
findings strongly suggest a prominent role of trophic factors
provided by the therapeutically applied MSCs [18e20].
Nevertheless, the harsh microenvironment within a
degenerative IVD may compromise the viability and activity
of externally delivered cell populations. In particular,
several in vitro studies indicate that low pH conditions
(similar to the situation within a degenerative IVD) severely
impair the survival of exposed MSCs [21,22]. This suggests
that the degenerative state of an IVD may play a critical
role with respect to the effectiveness of a MSC trans-
plantation therapy. Indeed, results from a previous rabbit
disc degeneration model suggest that the severity of disc
degeneration may influence the therapeutic effect of MSCs
[23]. However, this has not been verified in a large animalmodel. Evaluation of new therapies in a bioreactor model is
an important intermediate step for their translation.
In the present study, we used a bovine whole IVD organ
culture model in a mechanical loading bioreactor to analyse
the effects of implanted MSCs. The well-established IVD
bioreactor systems allow the culture of whole IVDs under
defined mechanical and nutritional conditions [24]. Since it
is difficult to obtain whole human IVDs in large numbers
(and with similar degenerative conditions), IVDs from large
animals (bovine, ovine, caprine) have been widely used as a
substitute for the human IVDs. IVDs from large animals are
the closest IVD models of the human IVD in terms of di-
mensions, diffusion properties (large diffusion distances),
cell types (loss of notochordal cells by adulthood), and
extracellular matrix (the nucleus cannot be removed by
simple aspiration like in the smaller animal models) [25].
The bovine and ovine caudal IVD models have been widely
used as they can be easily obtained from slaughterhouses.
Because these species do not present a naturally-occurring
degeneration (unlike chondrodystrophic dogs), several
methods have been used to induce degeneration as a pre-
lude to study regeneration, including detrimental, high-
frequency loading, injection of inflammatory molecules,
and injection of enzymes [24]. Specifically, Illien-Junger
et al [26] have shown that bioreactors can be used to
maintain IVDs in a healthy (physiological) state as well as to
induce early stages of degeneration, which were associated
with increased cell death and catabolism. Discs could be
maintained in a physiological condition under low-
frequency loading and sufficient nutrition (0.6 0.2 MPa,
8 h/d at 0.2 Hz, medium containing 4.5 g/L glucose), while
degeneration was initiated by applying high-frequency
loading in combination with limited nutrition
(0.6 0.2 MPa, 8 h/d at 10 Hz, medium containing 2 g/L
glucose) [26]. In another study, Mwale et al [27] used a
bovine whole IVD organ culture model to investigate the
effect of MSCs and Link N on early stages of IVD degener-
ation. They found that both MSCs and Link N can restore
glycosaminoglycan content in degenerated discs.
Here, we hypothesised that the state of the IVD at the
time of MSC implantation and the type of MSC carrier will
have an impact on the response to the treatment. To avoid
damaging the AF, a previously established nucleotomy
model through the endplate was used to investigate NP
restoration [28]. A transpedicular approach to access the
nucleus pulposus through the endplate has already been
described in a sheep model [29]. Fibrin hydrogel and saline
solution were compared as carriers for MSCs. Our data
indicate significantly different reactions of both host IVD
cells and graft MSCs depending on the IVD state and the MSC
carrier, improving our understanding of the efficiency of
MSC transplantation therapy.
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Whole IVD culture under simulated physiological
and degenerative conditions
Bovine IVDs including endplates (nZ 36; mean
heightZ 8.86 1.18 mm, mean diameterZ
13.64 1.27 mm) were excised from the tails of 6e8-
month-old calves obtained from a local abattoir, prepared
for organ culture as previously described, and randomly
assigned to either physiological or degenerative culture
conditions (Figure 1) [26].
Discs were cultured in either simulated physiological or
simulated degenerative conditions [26]. Physiological cul-
ture medium was composed of Dulbecco’s modified Eagle
medium (DMEM) containing 4.5 g/L glucose and supplied
with 100 U/mL penicillin and 100 mg/mL streptomycin (all
products from Gibco, Invitrogen, Basel, Switzerland), 0.1%
Primocin (Invivogen, LabForce, Muttenz, Switzerland), 2%
screened foetal bovine serum (FBS; Pan Biotech, Aiden-
bach, Germany), and 1% insulin-transferrin-selenium (ITSþ;
Corning, ThermoFischer Scientific, Reinach, Switzerland).
Physiological loading was performed at a low frequency
(0.1 Hz, 0.05 0.03 MPa, 3 h/d, 7 days) in an IVD bioreactor
system. The degenerative group was cultured in a degen-
erative culture medium composed of DMEM containing 2 g/L
glucose and the same components as above; discs were
loaded at a high frequency (10 Hz, 0.05 0.03 MPa, 3 h/d, 7
days). After each loading period, discs were moved to six-
well plates and kept in free swelling conditions (recovery
period). For all discs, culture medium was replaced every
day after loading.
Human MSC isolation and expansion
Human MSCs (hMSCs) were obtained from bone marrow
aspirates with written consent of the patient (ethical
approval KEK 2016-00141, Bern). hMSCs isolated by FicollFigure 1 Schematic overview of the experimental design. hMSCs
saline.gradient and adherence to tissue culture plastic were
expanded in a-minimum essential medium (Gibco, Invi-
trogen) containing 100 U/mL penicillin, 100 mg/mL strep-
tomycin, 10% FBS (Pan Biotech), and 5 ng/mL basic
fibroblast growth factor (Peprotech, Rocky Hill, CT, USA).
Early passage (P2eP4) hMSCs from six different donors were
used in this study (48.7 19.1 years, mean age and stan-
dard deviation).
Application of hMSCs to IVDs
Following physiological or degenerative culture, discs were
partially nucleotomised (defect diameterZ 4 mm) using an
endplate approach, which allowed the supplementation of
defined volumes of cell suspensions while preserving an
intact AF [28,29]. Discs were randomly assigned to one of
the following groups (nZ 6/group; approximately 150 mL/
defect): (1) hMSCs in fibrin (Baxter Biosurgery, Vienna,
Austria); (2) fibrin alone; (3) hMSCs in phosphate-buffered
saline (PBS); and (4) PBS alone. A fibrinogen concentra-
tion of 60 mg/mL was used to allow sufficient resistance to
dynamic loading, while preserving adequate cell viability
[30], thrombin/fibrinogen ratio was set at 0.03 U/mg and a
cell density close to native IVD was used (6 106 cells/mL)
for both fibrin and PBS groups. After 30 minutes, the end-
plate core was repositioned and sealed with poly-
methylmethacrylate (PMMA) cement (Vertecem Mixing Kit;
Synthes, Teknimed S.A., Bigorre, France; Figure 1) [28].
Discs were further cultured under physiological conditions
(physiological medium with 0.1% ε-aminocaproic acid [31];
low-frequency loading) for 7 days. Fibrin gels seeded with
hMSCs and cultured in well plates for the same period of
time were included as controls.
Cell viability, distribution and disc height
For cell viability experiments, hMSCs were labelled with
PKH26 (Sigma-Aldrich, Buchs, Switzerland) beforeZ human mesenchymal stem cells; PBSZ phosphate-buffered
Table 2 List of human genes analysed by real-time PCR
[32,34].
Gene Abbreviation
Aggrecan ACAN
Cytokeratin-19 KRT19
Carbonic anhydrase XII CA12
Ribosomal protein, large, P0 (endogenous
control)
RPLP0
PCRZ polymerase chain reaction.
46 M. Peroglio et al.application to IVDs. At the end of the culture period, the
endplates were removed with a scalpel and the fibrin gel
was collected with a spatula. Fibrin gels were stained with
10 mM Calcein AM (3 hours at 4C and 1 hour at 37C). Small
samples (3 mm 3 mm 3 mm) of inner AF (AFi) and outer
AF (AFo) and NP were stained with 10 mM Calcein AM/2 mM
ethidium homodimer (both from Sigma-Aldrich) (3 hours at
4C and 1 hour at 37C) and visualised as previously
described [32].
For sagittal histological sections, discs were fixed in 4%
buffered formalin, decalcified, and embedded in PMMA
[28]. For transversal sections, the intact endplate was
removed prior to embedding in cryocompound. Sections
(10 mm thick) were postfixed in 4% buffered formalin and
stained with Safranin O/Fast Green, as previously described
[33].
Disc height was measured using a calliper at selected
time points after loading and after free-swelling recovery.
Each disc was measured at four positions, and the average
value was used to calculate the percentage of disc height
change normalised to height at dissection (Day 0).
Gene expression
Fibrin-hMSC samples were lysed with 1 mL TRI reagent and 5
mL polyacryl carrier (Molecular Research Center, Cincinnati,
OH, USA). IVD was separated into AFo, AFi, and NP; tissues
(100e150 mg) were finely chopped and treated with 2 mg/
mL pronase (Roche, Sigma-Aldrich) in DMEM on an orbital
shaker (1 hour at 37C, 5 mL pronase solution/100 mg tis-
sue). Following addition of 1 mL FBS and two washes in PBS,
samples were frozen in liquid nitrogen and pulverised in a
custom-made pestle device. The resulting powder was
homogenised in TRI Reagent, mechanically disrupted with a
Tissue Lyzer (Qiagen, Hombrechtikon, Switzerland; 25 Hz, 6
minutes), and RNA was isolated according to the manu-
facturer’s instructions. For reverse transcription, TaqMan
reagents (ThermoFischer Scientific) were used for bovine
RNA, and SuperScript Vilo Synthesis kit (Invitrogen, Ther-
moFischer Scientific) was used for hMSC RNA. Expression
levels of genes of interest (Tables 1 and 2) were measured
by real-time PCR (QuantStudio 6 Flex: Applied Biosystems,
Rotkreuz, Switzerland) using the ddCt method [32,34,35].
For IVDs receiving hMSC treatment, the corresponding tis-
sue (NP, AFi, AFo) from IVDs without hMSCs (receiving fibrin
or saline alone) was used as the reference. Human COL1Table 1 List of bovine genes analysed by real-time PCR
[32,34].
Gene Abbreviation
Collagen type I COL1
Collagen type II COL2
Aggrecan ACAN
Matrix-metalloproteinase-3 MMP3
A disintegrin- like and a metallopeptidase
with thrombospondin type 1 motif 4
ADAMTS4
Ribosomal protein, large, P0 (endogenous
control)
RPLP0
PCRZ polymerase chain reaction.and COL2 could not be analysed due to the bovine RNA
presence in fibrin and lack of primers without cross-
reactivity with bovine RNA.
Statistical analysis
Statistical analyses were performed using Graph Pad Prism
version 7.0 (GraphPad Software; San Diego, CA, USA). After
confirming normal distribution, paired t-tests were per-
formed (p< 0.1 trend, p< 0.05 significant difference). For
gene expression analyses, 2ddCt data were log2 trans-
formed prior statistical analysis. Comparisons of a single
carrier type with and without hMSCs was performed using
dCt values.Results
Cell viability and distribution in nucleotomised IVDs
Fibrin gels effectively filled the nucleotomised space and
prevented swelling of the surrounding tissue (Figure 2A).
There was a good integration with the native tissue
(Figure 2B). hMSCs were > 95% viable and homogenously
distributed in the fibrin carrier (Figure 2C). When hMSCs
were supplied in PBS, NP showed an intrinsic capacity to
swell and partially refill the defect (Figure 2D), whereas
hMSCs were not observed in the IVD tissue surrounding the
defect (Figure 2E). The cells in the tissue surrounding the
defect were > 80% viable (Figure 2F), and the disc tissue
viability was not affected by the treatment used (fibrin or
PBS, with or without hMSCs).
Disc height changes
Fibrin gels were able to deform following cyclic loading
(Figure 3A) and recovery (Figure 3B). During pre-
conditioning, degenerative-loaded discs showed a lower
disc height recovery after loading than physiologically-
loaded discs that was significant at Day 2 (Figure 4A).
Following treatment, physiologically-loaded discs showed
an initial significantly higher disc height loss and trend for
lower recovery when treated with fibrin than with saline;
however, the differences became less strong with culture
time (Figure 4B). No differences were observed in the
presence or absence of hMSCs. Disc height changes of
degenerative-loaded discs following loading and recovery
were not significantly affected by the filler (Figure 4C).
Figure 2 Degenerative-loaded bovine intervertebral discs (IVDs) restored with human mesenchymal stem cells (hMSCs) in (A) and
(B) fibrin (D) and (E) and saline solution following 7 days of dynamic culture. (A) and (D) Safranin O/Fast green stained transversal
sections overviews (scale barZ 1 mm); (B) and (E) defect/tissue interface magnified views (scale barZ 100 mm); (C) combined
phase contrast and fluorescent images of fibrin gel with PKH26-labelled hMSCs stained with calcein AM (yellowZ viable
hMSC, redZ dead hMSC) and (D) nucleus pulposus tissue stained with calcein AM/ethidium homodimer (scale barZ 100 mm)
(greenZ viable disc cell; red/yellowZ dead disc cell). Note that fibrin prevents tissue swelling into the nucleotomised space and
limits proteoglycan loss, as attested by the stronger Safranin O stain (A vs. D); fibrin can fill irregularly shaped defects (B). Note the
homogeneous distribution of viable hMSCs in fibrin (C) and a majority of viable NP cells inside degenerated tissue (F). fZ fibrin gel;
npZ nucleus pulposus s Z saline.
Figure 3 Safranin O/Fast green stained methacrylate sagittal section of nucleotomised intervertebral discs treated with human
mesenchymal stem cells in fibrin gel collected immediately (A) after completion of the last dynamic loading cycle and (B) following
free swelling. Note the ability of fibrin to recover its initial shape following loading release. afZ annulus fibrosus; epZ endplate;
esZ endplate stopper; fZ fibrin gel with hMSCs; hMSCsZ human mesenchymal stem cells; npZ nucleus pulposus, Scale bar Z
1 mm.
Intervertebral disc response to stem cell treatment 47Effects of MSCs in physiological and degenerative
discs
The hMSC impact on physiologically-loaded discs was min-
imal and independent of the carrier (Figure 5A). In
degenerative-loaded discs, hMSC application using fibrin
significantly increased the expression of matrix-associated
genes (COL2 and ACAN) in IVD cells compared with the
hMSC delivery in saline (Figure 5B). The delivery of hMSCs in
combination with fibrin induced a stronger upregulation of
anabolic markers (COL1, COL2, ACAN) than fibrin alone(baseline in Figure 5B). Furthermore, the differentiation of
hMSCs was affected by the loading history of the discs
whereby physiological discs induced a significantly higher
expression of ACAN and CA12 in implanted hMSCs than the
degenerative ones (Figure 5C).Discussion
Our hypothesis was that IVD response to hMSC treatment
would be conditioned by: (1) the state of the disc and (2)
Figure 4 Evolution of disc height relative to the initial dimensions after dissection: (A) during pre-conditioning under physio-
logical (phys) or degenerative (deg) conditions (nZ 12) following treatment with fibrin gel or saline (PBS) in (B) physiological discs
and (C) degenerative discs (nZ 6). Note that the loading protocol induced a higher disc height recovery in physiologically-loaded
discs than in degenerative-loaded discs only in the initial phase of the loading (Day 2) and that these were levelled out in long term
(Day 7). In physiologically-loaded discs, treatment with saline (PBS) initially promoted a better preservation of disc height following
loading (Day 8 AL) and a higher swelling potential (Day 8 AR) than fibrin, but these differences were evened out in long term (Day
14). In degenerative-loaded discs, saline was ineffective in preserving disc height following loading both initially and in long term.
ALZ disc height after loading, ARZ disc height after free-swelling recovery. PBSZ phosphate-buffered saline.
Figure 5 Anabolic gene expression of intervertebral discs (IVDs) treated with human mesenchymal stem cells (hMSCs) in fibrin or
saline with a (A) physiological and (B) degenerative background. Data from NP, AFi, and AFo are combined. Data are expressed as
2ddCt relative to IVDs receiving the carrier alone (fibrin or PBS) (nZ 12); * indicates p< 0.05 relative to fibrin alone. (C) Expression
of NP cell markers in hMSCs cultured for 1 week in discs with a physiological or degenerative background. Data are expressed as
2ddCt relative hMSC-fibrin gel cultured in a well plate (nZ 12). KRT19: cytokeratin-19, CA12: carbonic anhydrase 12. Note that IVD
response to hMSCs was conditioned by both disc degenerative state and hMSC carrier. The effect of the regenerative treatment
with hMSCs in fibrin was stronger on simulated-degenerative discs than on simulated-physiological discs (B vs. A). hMSCs in fibrin
induced a superior anabolic response in degenerative IVDs compared with fibrin alone (*, B), suggesting an added value of the
cellular therapy compared with an acellular solution (B). When comparing fibrin and saline as hMSC carrier, a significantly higher
anabolic response was observed in IVDs treated with hMSCs in fibrin (A and B, COL2 and ACAN). The degenerative state of the disc
influenced hMSC differentiation with a significantly higher expression of specific discogenic markers (ACAN and CA12) in hMSCs
implanted into physiological discs than in those implanted into degenerative discs. AFiZ inner annulus fibrosus; AFoZ outer
annulus fibrosus; NPZ nucleus pulposus.
48 M. Peroglio et al.the type of carrier used for hMSC administration. Our re-
sults confirmed these assumptions: hMSC influence on
physiological discs was minimal, independent of carrier
type (Figure 5A); in contrast, hMSC delivery was beneficial
in degenerative discs when a fibrin carrier was used,
whereas hMSC contribution was limited when cells were
applied with a saline solution (Figure 5B). Our results
confirm in vitro findings of Strassburg et al [36] who showed
that hMSCs enhanced the expression of matrix-associated
genes in degenerate NP cells but had no effect on healthy
NP cells as well as in vivo findings by Ho et al [23] who
illustrated in a small-animal model that hMSC regenerative
effect was dependent on the severity of disc degeneration.
By providing a physical environment close to human IVD
(e.g., in terms of size and diffusion distances) [25], the
whole organ culture bovine caudal model used in this study
represents an important intermediate step for thetranslation of new therapies from bench to bedside. To the
best of our knowledge, this is the first organ culture study
that shows that disc response to stem cells is influenced by
the state of the disc and hMSC carrier.
The choice of an appropriate carrier for stem cell de-
livery was found to be important. Our results suggest that
the fibrin gels used in this study effectively filled the
nucleotomised space, prevented disorganisation of the
surrounding IVD tissue, supported stem cell viability
(Figure 2), and allowed paracrine signalling between hMSCs
and disc cells (Figure 5). Similar to the in vitro indirect co-
culture study by Yang et al [19], we found in our organ
cultures an upregulation of anabolic gene expression in
degenerative discs following exposure to hMSCs. Moreover,
appropriate carriers could avoid possible shortcomings
associated with hMSC delivery with saline solutions as the
latter have been associated with cell leakage and
Intervertebral disc response to stem cell treatment 49osteophyte formation [37]. The use of a carrier that is
capable of withstanding dynamic loading, such as the fibrin
gel used in this study (Figure 3), has two advantages: first,
hMSCs can sense the dynamic loading, which has been
shown to trigger hMSC chondrogenesis [7], and second, the
exchange of paracrine signals between hMSCs and disc cells
could be facilitated by dynamic loading conditions. Saline
was an inefficient carrier for hMSCs, possibly due to less
precise localisation of hMSCs in the IVD space and reduced
sensitivity to loading. In this respect, IVD bioreactors pro-
vide a favourable setting for such studies.
Previous in vivo studies have shown a positive effect of
stem cells on disc height preservation [38]. In our organ
culture model, stem cells did not influence disc height
(Figure 4); thus, longer cultures or an in vivo follow-up
study would be required to assess this point. We found
that saline solutions had an initial positive effect on the
height of IVDs with a physiological background, which could
be explained by a higher swelling potential than degener-
ative discs.
The response to hMSC treatment was stronger in
degenerative discs. Conversely, MSCs showed a better
differentiation potential towards IVD phenotype in physi-
ological discs. Therefore, we may speculate that hMSCs
delivered to healthy discs may differentiate towards the
disc-like phenotype, whereas hMSCs delivered to early
degenerative discs will release trophic factors that will
stimulate IVD cells to regain a healthy phenotype. Indeed,
recent in vivo work suggests that the inflammatory envi-
ronment associated with early stages of degeneration may
play a key role in promoting MSC paracrine effects [39].
The disc native environment has specific characteristics
(hypoxic, avascular, low glucose, hydrostatic pressure)
that have a strong impact on MSC behaviour (survival,
proliferation, differentiation, matrix synthesis) as
reviewed by Huang et al [40]. It has been shown that
hypoxia can promote stem cell proliferation and differ-
entiation towards the disc-like/ chondrogenic phenotype.
However, the combination of hypoxia and serum depriva-
tion has a negative impact on MSCs and can lead to cell
death. It has been repeatedly shown that cyclic mechan-
ical loading can stimulate hMSC chondrogenic differenti-
ation through transforming growth factor-b signalling, but
excessive load may be detrimental. The disc environment
changes with degeneration (acidic pH, vasculature infil-
tration, loss of hydrostatic pressure, presence of inflam-
matory cytokines, and matrix proteinases). Studies with
rat bone marrow MSCs have shown negative effects
in vitro that were proportional to pH acidity (ranging from
7.4 to 6.8), but effects of pH on human MSCs in IVDs are
still unknown. Vasculature infiltration may favour meta-
bolic exchanges and thus play a positive role on hMSC
survival. On the other hand, vasculature infiltration makes
the discs accessible to the immune cells, which can
further accelerate the degenerative cascade; however,
the exact role of IVD vascularisation on exogenous MSC
behaviour in human IVDs has not yet been clarified. It
should be noted that from a cellular point of view, co-
cultures of MSCs with degenerated IVD cells have shown
both the ability of MSCs to differentiate towards the disc
phenotype and the capacity of IVD cells to regain a
healthier phenotype.Limitations of the study are linked to the fact that only
early stages of degeneration were investigated. Indeed, it
is still an open challenge to reproduce ex vivo late stages of
disc degeneration that are representative of the human
condition. The chosen loading regime was relatively low,
and further studies will be needed to assess MSC therapies
in a more mechanically-challenging environment. Finally,
the trans-endplate model may be less close to the clinical
scenario than an approach through the AF. Nonetheless,
since AF closure remains an open challenge, the trans-
endplate approach [41] allows for the separate investiga-
tion of NP and AF repair.
The present study has several clinical implications. First,
pilot clinical studies have suggested that stem cell injection
(with saline as a carrier) contributes to reduce chronic back
pain [42,43]. Other studies have suggested a positive role of
saline injections in reducing radicular pain [44]; however, a
large clinical study has not been performed yet. Our results
suggest that the chosen fibrin composition may be a better
carrier than saline to induce regenerative changes in the
disc tissue. Second, with organ cultures, it is possible to
assess regenerative therapies not only at the macroscopic
level but also at the molecular level. For instance, in
addition to clinically-accessible parameters such as disc
height (which can be clinically measured by magnetic
resonance), it is possible to study changes in the expression
of genes of both the donor stem cells and host disc cells
(which to date cannot be investigated in the patients).
Third, organ cultures can provide a useful screening tool to
optimise stem cell carriers and help identify the most
promising approaches for translation in in vivo models and
later in humans. Towards this aim, modern imaging tech-
niques can nowadays detect the degenerative grade with
great precision and contribute to identify the patient
groups that can best benefit from the MSC treatment.
In conclusion, we found that the response of large ani-
mal nucleotomised IVDs to hMSC treatment was conditioned
by the IVD degenerative state and hMSC carrier. Adminis-
tration of hMSCs with fibrin through the endplate stimu-
lated the anabolic response of degenerative but not healthy
discs. Saline solution proved to be an inefficient carrier for
hMSCs in nucleotomised IVDs, highlighting the importance
of a careful selection of the cell carrier. Whole organ cul-
ture bioreactors can provide an important investigational
tool for the assessment and translation of stem cell-based
therapies. Further studies will focus on hMSC carrier opti-
misation and development of whole organ culture models
simulating different degeneration stages.Conflicts of interest
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